submit news    HOME | FEEDBACK  


« NAVIGATION »
NEWS

- Bio/Medicine

- Chemicals

- Defense

- Drug Delivery

- Education

- Electronics

- Energy

- Events

- Grants

- Industry

- Investment

- Litigation

- Materials

- MEMS

- Nanofabrication

- Nanoparticles

- Nanotubes

- Optics

- Partnership

- Patent

- Products

- Quantum dots

- Research

- Smart Dust

- Software
COMPANIES
EVENTS

- Browse by Month

- Current Shows

- Previous Shows

- Submit Events
FEEDBACK
ADVERTISE
LINK TO US

« PARTNERS »
Become A Nanotechwire Partner

FEI Company

Veeco Instruments

Nano Science and Technology Institute

National Nanotechnology Initiative

Nanotechnology at Zyvex

Want to see your Company or Organization listed above? Become A Nanotechwire Partner Today - click here
« NEWSLETTER »



« SEARCH »







12/6/2010 7:20:58 PM
Fluidigm Files S-1 Registration Statement for Initial Public Offering

Fluidigm Corporation announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of Fluidigm's common stock. Fluidigm develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. The shares in the offering will be offered by Fluidigm. The number of shares to be offered and the price range for the offering have not yet been determined.

Deutsche Bank Securities Inc. and Piper Jaffray & Co. are acting as book-runners for the offering.

Copies of the preliminary prospectus for the offering, when available, may be obtained from Deutsche Bank Securities Inc., Deutsche Bank Securities Inc., Attn: Prospectus Department, 100 Plaza One, Floor 2, Jersey City, NJ 07311, or by calling (800) 503-4611 or emailing a request to prospectusrequest@list.db.com or Piper Jaffray & Co., 800 Nicollet Mall, Suite 800, Minneapolis, MN 55402, or by calling (800) 747-3924.

A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

http://www.fluidigm.com

Other Headlines from Fluidigm ...
 - Fluidigm Launches Low-Cost Assays for Gene Expression, SNP Genotyping and Target-Specific Primers for Next-Generation Sequencing
 - Fluidigm Delivers More Than One Billion Microscopic NanoFlex Valves
 - Fluidigm Introduces Its Most Advanced Genomic Analysis System – The BioMark HD Real-Time PCR System
 - Fluidigm Files S-1 Registration Statement for Initial Public Offering
 - Fluidigm Introduces World’s First Reusable Bio-Chip for SNP Genotyping

More Investment Headlines ...
 - 3M Invests in GoNano Technologies Inc.
 - Nanostart Launches Nanotechnology Fund in Russia
 - Ultratech Announces First Quarter 2011 Results
 - BioNanomatrix Secures $23.3 Million in Series B Financing
 - State Corporation RUSNANO Reorganized as Open Joint-Stock Company


« Back To List »

« GET LISTED »
- submit company
- submit news
- submit events
- advertise here

« EVENTS »
- More Events


Copyright © 2017 Nanotechwire.com | Privacy Policy |